UnitedHealth's diversified model, robust financials, and undervaluation signal a 24% upside. Click to read more on why I ...

UnitedHealth Group recently announced plans to exit its Latin American operations. It acquired Banmedica in 2018 as a way to ...

UnitedHealth Group (NYSE:UNH) recently reached a $69 million settlement in a fiduciary duty lawsuit, underscoring its legal ...

UnitedHealth Group Inc. is cutting commissions for brokers on some Medicare Advantage plans, according to documents reviewed ...

Shares of UnitedHealth Group have sold off considerably this year, as bad news surrounding the company continues to pile up.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

If you're seeking dividend income, bravo -- because dividends are hard to beat. One dividend payer to consider is ...

More bad news came in 2025. UnitedHealth Group reported lower-than-expected first-quarter earnings in April. The company ...

UnitedHealth Group shares appear undervalued after 50% decline, and concerns about a potential DOJ investigation seem overblown. Click to read why UNH is a Buy.

Delving into the details, we found 30% of traders were bullish, while 65% showed bearish tendencies. Out of all the trades we ...

UnitedHealth Group Incorporated (NYSE:UNH) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. On June 11, ...

Fintel reports that on June 11, 2025, Baird downgraded their outlook for UnitedHealth Group (NYSE:UNH) from Outperform to ...